Harold W. Horowitz, et al., published the research letter, “COVID-19 and the Consequences of Anchoring Bias” in the CDC’s August publication of the monthly journal, Emerging Infectious Diseases. The authors disclose how suspected coronavirus disease in febrile patients can influence healthcare providers’ decisions and may result in misdiagnosing other serious infections with epidemiologic risk.
Covid-19 and Lyme Disease
We have assembled useful articles to help guide you and your loved ones as we enter the “new normal”.
Please stay safe – we are all in this together!
A new protocol for patients suffering from Long Haul COVID-19 Syndrome (LHCS) has been developed in a collaboration led by Dr. Mobeen Syed (“Dr. Been”), Dr. Ram Yogendra, Dr. Bruce Patterson, Dr. Tina Peers, and the Front Line COVID-19 Critical Care Alliance (FLCCC). The protocol, I-RECOVER, is based on the group’s experiences using certain therapies […]
Increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna) since April 2021, particularly in adolescents and young adults. These rates for ages 16-24 following a second dose are above what is expected. Myocarditis or pericarditis has now been verified in 226 people ages 30 and younger who have received an mRNA COVID-19 vaccine and Federal Health Officials are investigating reports of approximately 250 more cases.
Due to this increase, the Advisory Committee on Immunization Practices (ACIP) is scheduled to hold an emergency meeting on June 18, 2021 to discuss myocarditis cases and the American Academy of Pediatrics (AAP) plans to closely monitor meeting.
Judge James Orel of DuPage County in Illinois ordered Edward-Elmhurst Hospital to give the drug, ivermectin, to a 68-year-old COVID-19 patient who had failed other treatments. The patient, in intensive care for over a month, in a coma, and on a ventilator was not improving. Her daughter read the news story about a Buffalo, New […]
The Clinician Outreach and Communication Activity (COCA)/Center for Disease Control is offering a conference call on May 20th, 2020: Lyme Disease Updates and New Educational Tools for Clinicians from 2:00–3:00 P.M. ET. See right side of page for instructions on how to join the call via zoom or phone. Advanced registration is not required. During […]
Assessing the Safety Profile of mRNA-Based Vaccines in Patients with Autoimmune Inflammatory Rheumatic Diseases
A case series assessing the safety profile of mRNA-based vaccines in patients with autoimmune inflammatory rheumatic diseases (AIIRD) has been published in the journal Rheumatology. The study’s authors aim to raise awareness of reactivation of herpes zoster (HZ) following the BNT162b2 mRNA vaccination in patients with AIIRD.
The LDA is compiling a list of articles in the news & journals of possible interest regarding Covid-19 & Lyme disease. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies (Clinical Medicine – London) Melanie Dani, et al. Lyme Disease in the Era of COVID-19: A Delayed Diagnosis and Risk for Complications (Case Reports […]
Pfizer CEO, Albert Bourla, announced yesterday that an antiviral pill to treat Covid-19 may be available by the end of the year. The pill, taken orally at home, would be effective at the first sign of Covid-19 infection or exposure, and is expected to be effective against variants. Pfizer is testing two antivirals, one intravenous […]
An April 14, 2021 PLOS 1 study, Cynthia Otto et al., 2021, suggests that specially trained dogs can sniff out COVID-19 samples with 96% accuracy. The study, “Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study,” comes out of the University of Pennsylvania School of Veterinary Medicine Working Dog Center. […]
According to a Dartmouth-Hitchcock press release, Dartmouth-Hitchcock Medical Center (DHMC) was one of 18 sites that conducted patient trials with lenzilumab and found this drug to be a safe, well-tolerated, and highly effective treatment against COVID-19.